Cargando…
An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade
The ongoing coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is a global concern and necessitates efficient drug antagonists. Angiotensin-converting enzyme-2 (ACE2) is the main receptor of SARS-CoV-2 spike 1 (S1), which med...
Autores principales: | Han, Songling, Zhao, Gaomei, Wei, Zhuanzhuan, Chen, Yin, Zhao, Jianqi, He, Yongwu, He, Ying-Juan, Gao, Jining, Chen, Shilei, Du, Changhong, Wang, Tao, Sun, Wei, Huang, Yi, Wang, Cheng, Wang, Junping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375220/ https://www.ncbi.nlm.nih.gov/pubmed/34419496 http://dx.doi.org/10.1016/j.peptides.2021.170638 |
Ejemplares similares
-
γ-Core Guided Antibiotic Design Based on Human Enteric Defensin 5
por: Zhao, Gaomei, et al.
Publicado: (2022) -
Irradiation pretreatment enhances the therapeutic efficacy of platelet-membrane-camouflaged antitumor nanoparticles
por: Chen, Yin, et al.
Publicado: (2020) -
Screening of an annexin‐A2‐targeted heptapeptide for pancreatic adenocarcinoma localization
por: Ma, Heyao, et al.
Publicado: (2022) -
Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2
por: Wang, Yong, et al.
Publicado: (2012) -
Corrigendum to “Cardioprotective Effects of Qishenyiqi Mediated by Angiotensin II Type 1 Receptor Blockade and Enhancing Angiotensin-Converting Enzyme 2”
por: Wang, Yong, et al.
Publicado: (2019)